Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 22Plasma cell 4Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Venous Thromboembolism 4Multiple Myeloma 4Pulmonary Embolism 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1

Interventions

apixaban 4Rivaroxaban 2enoxaparin sodium 1Tinzaparin 1Observation 1Heparin, Low-Molecular-Weight 1Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Venous Thromboembolism × apixaban × Plasma cell × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

University Hospital, Grenoble

Phase 3 Completed
108 enrolled
Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Instituto de Investigacion Sanitaria La Fe

Phase 2 Terminated
60 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Dana-Farber Cancer Institute

Phase 4 Completed
50 enrolled 5 charts
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡